Dr. Ahmed Idbaih is an associate professor at Sorbonne University and an attending neuro-oncologist at Pitié-Salpêtrière Hospital in Paris. Dr. Idbaih obtained his M.D at Pierre et Marie-Curie University. He specialized in neurology and neuro-oncology and in parallel, he obtained his Ph.D. in molecular oncology at Paris XI University. Dr. Idbaih completed a postdoctoral fellowship at Dana Farber Cancer Institute in Boston. Currently, he is a neuro-oncologist in the department of Neurology 2-Mazarin at Pitié-Salpêtrière hospital where he manages mainly glioma patients. He is involved in several clinical trials dedicated to primary brain tumor patients. He conducts his biological research at the Brain and Spine Institute (ICM) in Pitié-Salpêtrière hospital. He is interested in the identification of molecular biomarkers in malignant brain tumors and the evaluation of innovative therapeutic strategies in relevant preclinical models of glioblastoma.